Sentence examples for dose demonstrated a from inspiring English sources

Percentages of abstracts dealing with radiation dose demonstrated a general increase for all examined dose categories, in correlation most pronounced in the category of dose reduction (Fig. 6).

Subjects who matched carbohydrate amount and insulin dose demonstrated a further improvement in glycemic control (2).

Inoculum dose demonstrated a significant positive correlation with total spore production and was used as a covariate in the analysis.

All GP MDI doses demonstrated a rapid onset of action, and the 115.2 μg dose demonstrated a significantly faster onset than TIO 18 μg.

MMX mesalazine 2.4 g/day administered as a single or divided dose demonstrated a good safety profile, was well tolerated and was effective as maintenance treatment.

DAS28-CRP<2.6 DAS28-CRP<2.6 DAS28-CRP<2.6n all tratesd groups; the 100 mg dose demonstrated a sincreasedt effect (23.1% vs 6.7%; p=0.016) by week 12 and the number overubjectimechinving Dall8-CRP<2.6 was streatedcreasingroupseek 12 (figure 2A–C).

In fact, the multiple model adjusting for the delivered 5-FU dose demonstrates a significantly positive impact of IFN on OS, but not on DFS.

Each r-GV elicits a solid peptide specific antibody response to the initial low dose, demonstrates a secondary response to the booster and a natural waning of antibody titer over time, as shown by assay of the 12 week post booster sera.

It is noteworthy that biotin-decorated PMM carrying NCL at low doses demonstrated a significantly higher cytotoxicity than free NCL in CPr-A549.

The 10-nm PS-Ag had no significant effects on the Vero cells in the first 24 h (Figure 1), but the 75 and 100 μg/ml doses demonstrated a 25% reduction in viability after 48 h (data not shown), suggesting an instability of the coating.

Both galcanezumab doses demonstrated a statistically significant improvement compared with placebo (both studies p<.001) for overall mean change in monthly MHD (EVOLVE-1: placebo=-2.81; GMB 120 mg=-4.73; GMB 240 mg=-4.57; EVOLVE-2: placebo=-2.28; GMB 120 mg=-4.29; GMB 240 mg=-4.18 mg=-4.18